Neurosona Participates in International Medical Device Exhibition 'Arab Health 2023'

[Asia Economy Reporter Hyungsoo Park] Neurosona, a specialized company developing electronic medicine for brain disease treatment, announced on the 3rd that it participated in the international medical device exhibition 'Arab Health 2023' held in Dubai.

Celebrating its 48th edition this year, 'Arab Health 2023' is the largest international medical device exhibition in the Middle East, held from the 30th of last month to the 2nd of this month.

Neurosona was selected as an excellent performing company in the '2022 Support Project' by the Korea Health Industry Development Institute and participated as an exhibitor in the Korean Medical Device Integrated Pavilion established by the institute. At the exhibition, it showcased the 'Low-Intensity Focused Ultrasound Stimulation System,' designated as an innovative medical device, attracting attention on-site.

Neurosona is a brain disease treatment electronic medicine developer conducting clinical trials applying the 'Low-Intensity Focused Ultrasound Stimulation System' to various brain disease patients including those with depression, Alzheimer's, pain, consciousness disorders after traumatic brain injury, sleep disorders, and brain tumors (anticancer drug delivery). Neurosona's non-invasive 'Low-Intensity Focused Ultrasound Stimulation System' for treating intractable brain diseases was designated as an innovative medical device by the Ministry of Food and Drug Safety in August 2021.

Neurosona signed a Memorandum of Understanding (MOU) with the UAE medical specialized company 'Atlas Medical.' They agreed to cooperate in entering the medical device market in the Middle East.

This content was produced with the assistance of AI translation services.